196 related articles for article (PubMed ID: 17121888)
1. Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients.
Querzoli P; Pedriali M; Rinaldi R; Lombardi AR; Biganzoli E; Boracchi P; Ferretti S; Frasson C; Zanella C; Ghisellini S; Ambrogi F; Antolini L; Piantelli M; Iacobelli S; Marubini E; Alberti S; Nenci I
Clin Cancer Res; 2006 Nov; 12(22):6696-701. PubMed ID: 17121888
[TBL] [Abstract][Full Text] [Related]
2. Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement.
Colleoni M; Rotmensz N; Peruzzotti G; Maisonneuve P; Mazzarol G; Pruneri G; Luini A; Intra M; Veronesi P; Galimberti V; Torrisi R; Cardillo A; Goldhirsch A; Viale G
J Clin Oncol; 2005 Mar; 23(7):1379-89. PubMed ID: 15735114
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes.
Andersson Y; Frisell J; Sylvan M; de Boniface J; Bergkvist L
J Clin Oncol; 2010 Jun; 28(17):2868-73. PubMed ID: 20458033
[TBL] [Abstract][Full Text] [Related]
4. Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure.
Montagna E; Viale G; Rotmensz N; Maisonneuve P; Galimberti V; Luini A; Intra M; Veronesi P; Mazzarol G; Pruneri G; Renne G; Torrisi R; Cardillo A; Cancello G; Goldhirsch A; Colleoni M
Breast Cancer Res Treat; 2009 Nov; 118(2):385-94. PubMed ID: 19562480
[TBL] [Abstract][Full Text] [Related]
5. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
[TBL] [Abstract][Full Text] [Related]
7. Detection of micrometastases in pelvic lymph nodes in patients with carcinoma of the cervix uteri using step sectioning: Frequency, topographic distribution and prognostic impact.
Horn LC; Hentschel B; Fischer U; Peter D; Bilek K
Gynecol Oncol; 2008 Nov; 111(2):276-81. PubMed ID: 18722005
[TBL] [Abstract][Full Text] [Related]
8. Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories.
Pugliese MS; Beatty JD; Tickman RJ; Allison KH; Atwood MK; Szymonifka J; Arthurs ZM; Huynh PP; Dawson JH
Ann Surg Oncol; 2009 Jan; 16(1):113-20. PubMed ID: 18949520
[TBL] [Abstract][Full Text] [Related]
9. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
[TBL] [Abstract][Full Text] [Related]
10. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
11. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
Reed W; Bøhler PJ; Sandstad B; Nesland JM
Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of axillary lymph-node micrometastases in breast cancer patients.
Kuijt GP; Voogd AC; van de Poll-Franse LV; Scheijmans LJ; van Beek MW; Roumen RM
Eur J Surg Oncol; 2005 Jun; 31(5):500-5. PubMed ID: 15922886
[TBL] [Abstract][Full Text] [Related]
13. Distinction between isolated tumor cells and micrometastases in breast cancer: is it reliable and useful?
de Mascarel I; MacGrogan G; Debled M; Brouste V; Mauriac L
Cancer; 2008 Apr; 112(8):1672-8. PubMed ID: 18286534
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of isolated tumor cells in breast cancer axillary nodes: single tumor cell(s) versus tumor cell cluster(s) and microanatomic location.
Vestjens JH; de Boer M; van Diest PJ; van Deurzen CH; van Dijck JA; Borm GF; Adang EM; Bult P; Tjan-Heijnen VC
Breast Cancer Res Treat; 2012 Jan; 131(2):645-51. PubMed ID: 21927853
[TBL] [Abstract][Full Text] [Related]
15. Impact of micrometastases in the sentinel node of patients with invasive breast cancer.
Hansen NM; Grube B; Ye X; Turner RR; Brenner RJ; Sim MS; Giuliano AE
J Clin Oncol; 2009 Oct; 27(28):4679-84. PubMed ID: 19720928
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
17. Role of lymph node dissection in the treatment of urothelial carcinoma of the upper urinary tract: multi-institutional relapse analysis and immunohistochemical re-evaluation of negative lymph nodes.
Abe T; Shinohara N; Muranaka M; Sazawa A; Maruyama S; Osawa T; Harabayashi T; Kubota K; Matsuno Y; Shibata T; Toyada Y; Shinno Y; Minami K; Sakashita S; Kumagai A; Takada N; Togashi M; Sano H; Mori T; Nonomura K
Eur J Surg Oncol; 2010 Nov; 36(11):1085-91. PubMed ID: 20832972
[TBL] [Abstract][Full Text] [Related]
18. Central mesenteric lymph node BER-Ep4+ cells in colorectal cancer: challenge to sentinel node concept?
Schurr PG; Behnke S; Kaifi JT; Bogoevski D; Link B; Mann O; Strate T; Pantel K; Izbicki JR; Yekebas E
Dig Surg; 2007; 24(1):19-27. PubMed ID: 17369677
[TBL] [Abstract][Full Text] [Related]
19. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
Bulte CS; van der Heiden-van der Loo M; Hennipman A
Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
[TBL] [Abstract][Full Text] [Related]
20. Micrometastases in axillary lymph nodes and bone marrow of lymph node-negative breast cancer patients--prognostic relevance after 10 years.
Gebauer G; Fehm T; Merkle E; Jaeger W; Mitze M
Anticancer Res; 2003; 23(5b):4319-24. PubMed ID: 14666645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
